undamentalytics Newsletter
Sign in

Amneal Pharmaceuticals, Inc. balance sheet

At the end of fiscal 2025, Amneal Pharmaceuticals, Inc. had total assets of $3.68bn and shareholders' equity of −$70.8m. It held $282m in cash against $2.69bn of debt: net debt of $2.41bn.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents27742131513412482692111282128
Receivables—351481604639663742————
Inventory—284457381491489531581612606678
Total current assets—7721,2871,2101,5521,5201,4121,3781,5881,9111,947
Goodwill2826426420523593599599597595593
Total assets—1,3424,3533,6664,0063,9403,7993,4733,5013,6783,776
Accounts payable—70115103153131166144259——
Total current liabilities—2975545506776777538471,130882883
Short-term debt—8921214431303422476
Long-term debt—1,3552,6312,6092,7352,6802,5922,3862,1622,5652,564
Total debt01,4442,6872,6602,8062,7312,6822,5992,4862,6952,684
Total liabilities—0—————————
Shareholders' equity—050523230336029820−109−7133
Non-controlling interests and other (assets − liabilities − equity)—1,342—————————
Net debt (negative = net cash)−271,3702,4732,5082,4642,4832,6562,5082,3752,4132,557
Shares outstanding———————————

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: AMRX vs RPRXAMRX vs JAZZAMRX vs ELAN

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Amneal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Amneal Pharmaceuticals, Inc.